Dialog window

Development journey

Services

Bio|Verse®

Case studies

About

Careers

News

Let’s discuss how we can turn your data into real scientific impact.

Contact us >

De-risking & automating antibody discovery through rationalisation of in-vitro maturation

De-risking & automating antibody discovery through rationalisation of in-vitro maturation

by admin | Dec 13, 2025

After selecting a binder, the client wanted to improve its potency by rationalising invitro maturation. Manual screening of mutations is labour-intensive and error-prone. Our Approach We applied AbQuery and Antibody-extractor to rationalise in-vitro maturation and...

Recent Posts

  • BioLizard Wins 2025 BioTech Breakthrough Award For “Bioinformatics Innovation of the Year”
  • Why bioinformatics workflows require experienced software engineers
  • Industry leader and multi-omics pioneer joins leadership team to advance AI-driven solutions
  • The Vlerick Venture Award 2025 goes to Liesbeth Ceelen
  • BioLizard Logs Stellar First Half of 2025: Growth, Innovation & Recognition

Recent Comments

No comments to show.

Stay informed & inspired

Sign up for the BioLizard newsletter to receive monthly updates on our latest news & insights from the intersection of biology and data science.

Sign up →

Follow us

  • Follow
  • Follow
  • Follow

Recognized by

Headquarters

BioLizard nv
Foreestelaan 88
9000
Ghent, Belgium

US Office

BioLizard Inc.
IMS 1700 W Irving Park Rd Ste 209A
Chicago, IL
60613 USA

NL Office

BioLizard bv
Herengracht 420
1017 BZ Amsterdam, Netherlands

CH Office

BioLizard SA
Digital Health Hub – Biopôle
Bâtiment Phenyl Rte de la Corniche 3 1066 Epalinges, Switzerland

©2026 BioLizard nv. All rights reserved.

Privacy policy